Edition:
United States

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

17.30USD
27 Jun 2017
Change (% chg)

$1.58 (+10.05%)
Prev Close
$15.72
Open
$16.00
Day's High
$17.68
Day's Low
$15.91
Volume
784,840
Avg. Vol
315,197
52-wk High
$17.68
52-wk Low
$5.57

OSUR.OQ

Chart for OSUR.OQ

About

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $908.03
Shares Outstanding(Mil.): 57.76
Dividend: --
Yield (%): --

Financials

  OSUR.OQ Industry Sector
P/E (TTM): 30.46 34.12 19.11
EPS (TTM): 0.52 -- --
ROI: 15.54 13.11 -5.00
ROE: 15.98 15.62 -4.24

BRIEF-Orasure Technologies reports agreement with Bill & Melinda Gates Foundation

* Orasure Technologies - announced agreement with Bill & Melinda Gates Foundation,will enable co to offer or a quick HIV self-test at an affordable price

6:03am EDT

BRIEF-OraSure Tech appoints Mara Aspinall to board of directors

* OraSure Technologies appoints Mara G. Aspinall to board of directors

Jun 22 2017

BRIEF-Orasure announces Q1 revenue $32.5 million

* Q1 earnings per share view $0.18 -- Thomson Reuters I/B/E/S

May 03 2017

BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies

* Grifols - announces that it has restated its 2005 agreement with Orasure Technologies

Apr 24 2017

BRIEF-OraSure receives global fund classification to enable HIV self-test procurement

* OraSure Technologies Inc - OraSure receives global fund classification to enable HIV self-test procurement

Mar 01 2017

BRIEF-OraSure announces 2016 fourth quarter and full-year financial results

* OraSure announces 2016 fourth quarter and full-year financial results

Feb 08 2017

BRIEF-Orasure Technologies announces settlement of litigation with ancestry.comdna

* Says under a settlement and license agreement executed by parties, ancestry has agreed to pay DNA Genotek a settlement fee of $12.5 million

Feb 06 2017

More From Around the Web

Earnings vs. Estimates